$153.43
-15.15-8.99%
Last update: Nov 5, 7:58 PM

The average analyst price target for Guardant Health is $170.07, 23.7% above the current price. Of 26 analysts, 26 rate it Buy. Targets range from $60 to $225. The latest change came on Oct 27, 2026, when BTIG raised its price target on Guardant Health from $195 to $210 and kept a Buy rating.
Price Target Range — 8 Quarters
Analyst Consensus — 26 Analysts
Rating Trend — Last 9 Months